Scholarlink

<p>Ischemic stroke is a leading cause of death and permanent disability worldwide. There is an urgent need to identify novel therapeutic targets. Through bioinformatics analysis of Gene Expression Omnibus (GEO) datasets and the construction of protein–protein interaction (PPI) network, we identified hematopoietic cell kinase (HCK) as a key regulatory factor in ischemic stroke. In the rat middle cerebral artery occlusion (MCAO) model, we observed that HCK expression was significantly upregulated following cerebral ischemia. HCK knockdown markedly attenuated cerebral injury and mitochondrial dysfunction in MCAO rats. Meanwhile, we observed that HCK expression was significantly upregulated in N2a cells following oxygen and glucose deprivation (OGD) treatment. Silencing of HCK significantly suppressed apoptosis and mitigated mitochondrial dysfunction as evidenced by preventing the decrease in mitochondrial membrane potential (MMP), inhibiting mitochondrial permeability transition pore (mPTP) opening, reducing mitochondrial reactive oxygen species (ROS) production, and inhibiting the aberrant expression of dynamic related protein 1 (DRP1) and mitofusin 2 (MFN2) following OGD treatment. Mechanistically, we demonstrated that HCK acted as an upstream regulator of p38 and mediated OGD-induced N2a cells injury and mitochondrial dysfunction via the activation of p38. Collectively, our findings indicate that HCK plays a significant role in cerebral ischemic injury and mitochondrial dysfunction, highlighting it as a promising therapeutic target for neuroprotective strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hematopoietic Cell Kinase Promotes Cerebral Ischemic Injury and Mitochondrial Dysfunction via p38 Activation in Ischemic Stroke

  • 期刊论文

  • 发表日期：

    2026年1月1日

查看全文
  • Yaodong Lv,
  • Maowen Ba,
  • Zhigang Liang,
  • Jinyu Xiang,
  • Qinjian Sun

摘要

Ischemic stroke is a leading cause of death and permanent disability worldwide. There is an urgent need to identify novel therapeutic targets. Through bioinformatics analysis of Gene Expression Omnibus (GEO) datasets and the construction of protein–protein interaction (PPI) network, we identified hematopoietic cell kinase (HCK) as a key regulatory factor in ischemic stroke. In the rat middle cerebral artery occlusion (MCAO) model, we observed that HCK expression was significantly upregulated following cerebral ischemia. HCK knockdown markedly attenuated cerebral injury and mitochondrial dysfunction in MCAO rats. Meanwhile, we observed that HCK expression was significantly upregulated in N2a cells following oxygen and glucose deprivation (OGD) treatment. Silencing of HCK significantly suppressed apoptosis and mitigated mitochondrial dysfunction as evidenced by preventing the decrease in mitochondrial membrane potential (MMP), inhibiting mitochondrial permeability transition pore (mPTP) opening, reducing mitochondrial reactive oxygen species (ROS) production, and inhibiting the aberrant expression of dynamic related protein 1 (DRP1) and mitofusin 2 (MFN2) following OGD treatment. Mechanistically, we demonstrated that HCK acted as an upstream regulator of p38 and mediated OGD-induced N2a cells injury and mitochondrial dysfunction via the activation of p38. Collectively, our findings indicate that HCK plays a significant role in cerebral ischemic injury and mitochondrial dysfunction, highlighting it as a promising therapeutic target for neuroprotective strategies.